Avid Bioservices Inc (CDMO)

[BKT]

Curious about anyone's thoughts of where we stand if we have to wait until the end of 2016 until the completion of the Lung Cancer Phase III trial:

1) Would that mean the first two look ins were not significant enough to stop the trial? What would the comfort level be at that time knowing the first two look ins didn't accomplish what we are all hoping happens in the first look in?

2) Would 2 more years of waiting allow other big pharmas to further push their current developments in the immunotherapy arena?

Have always figured not a question of if, but when, and assumed the when would be no later than June of 2015, but starting to rethink based upon this company's lack of information and defense of the share price. With dozens of collaborations, 141 sites opened, patients being dosed, partnerships trying to be negotiated, you would think that this share price would be climbing and climbing fast if things were looking good, since nothing is airtight.

Maybe I'm freaking a bit, but dam roller coaster ride kills me.